omega-n-methylarginine has been researched along with tolbutamide in 5 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tolbutamide) | Trials (tolbutamide) | Recent Studies (post-2010) (tolbutamide) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 5,368 | 238 | 265 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | tolbutamide (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.392 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, LY; Li, JS; Schiffrin, EL | 1 |
| Banitt, P; Creager, MA; Lipson, DE; Rongen, GA; Smits, P; Williams, SB | 1 |
| Iida, M; Iwase, M; Nakamura, U; Nohara, S; Sasaki, N; Sonoki, K; Uchizono, Y | 1 |
| Bouw, MP; Dorresteijn, MJ; Pickkers, P; Smits, P; van der Hoeven, JG | 1 |
| Brito, GA; Cunha, FQ; Ferreira, SH; Lotufo, CM; Ribeiro, RA; Sachs, D; Vale, ML | 1 |
1 trial(s) available for omega-n-methylarginine and tolbutamide
| Article | Year |
|---|---|
In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Topics: Adult; Dose-Response Relationship, Drug; Endotoxemia; Endotoxins; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Female; Forearm; Hemodynamics; Humans; Inflammation; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Regional Blood Flow; Tetraethylammonium; Tolbutamide; Vasoconstriction | 2006 |
4 other study(ies) available for omega-n-methylarginine and tolbutamide
| Article | Year |
|---|---|
Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats.
Topics: Acetylcholine; Adult; Animals; Apamin; Arginine; Arterioles; Charybdotoxin; Endothelium, Vascular; Humans; Hypertension; In Vitro Techniques; Indomethacin; Male; Methylene Blue; Middle Aged; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Ouabain; Potassium Chloride; Rats; Rats, Inbred SHR; Scorpion Venoms; Tolbutamide; Vasoconstriction | 1995 |
Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Topics: Adenosine; Arginine; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Potassium Channels; Quinidine; Regional Blood Flow; Tolbutamide; Vasodilation; Vasodilator Agents; Verapamil | 1995 |
Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in rats.
Topics: 3-O-Methylglucose; Administration, Oral; Anesthesia; Animals; Blood Glucose; Blood Pressure; Consciousness; Cyclohexanes; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Gastrointestinal Tract; Glucose; Hypoglycemic Agents; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nateglinide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylalanine; Rats; Rats, Inbred OLETF; Rats, Sprague-Dawley; Regional Blood Flow; Time Factors; Tolbutamide | 2005 |
Peripheral antinociceptive effect of pertussis toxin: activation of the arginine/NO/cGMP/PKG/ ATP-sensitive K channel pathway.
Topics: Adenosine Triphosphate; Analgesia; Analgesics; Animals; Arginine; Bucladesine; Carbazoles; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dinoprostone; Enzyme Inhibitors; Ganglia, Spinal; Glyburide; Indoles; KATP Channels; Male; Neurons; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Pain; Pain Measurement; Pertussis Toxin; Potassium Channels, Inwardly Rectifying; Quinoxalines; Rats; Rats, Wistar; Signal Transduction; Tolbutamide | 2006 |